New device for analyzing lipoproteins in blood to assess cardiovascular risk
Official title: Next-Generation Cardiovascular Risk Assessments Via State-Of-The-Art Lipoprotein Characterization
Funded at Electronic Biosciences, INC. · NIH-11007709 · Data updated 2026-11-12
This study is working on a new, easy-to-use device that can quickly and accurately check the levels of important particles in your blood that help show how healthy your heart is, making it simpler and cheaper for you to keep an eye on your heart health.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Electronic Biosciences, INC. NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project start | September 20, 2024 |
| Project end | September 19, 2025 |
| Funding year | 2024 |
| Award (this year) | $400,000 |
| NIH project number | 1R43HL174365-01A1 |
| Project ID | NIH-11007709 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for cardiovascular diseases, including those with high cholesterol, diabetes, or a family history of heart conditions.
✕Less likely to help
Patients who are not at risk for cardiovascular diseases or those who do not have any related health concerns may not benefit from this research.
What this research studies
This research focuses on developing an innovative analytical device that can accurately measure lipoprotein particles in blood, which are crucial indicators of cardiovascular health. By characterizing the size, concentration, and properties of these lipoproteins, the device aims to provide a more precise assessment of a patient's risk for conditions like atherosclerosis and heart disease. Unlike current tests that are complex and costly, this new technology is designed to be compact, affordable, and suitable for quick, point-of-care testing, making it accessible for regular monitoring. Patients will benefit from a more reliable and efficient way to evaluate their cardiovascular health.
Why it matters
Potential benefit: If successful, this research could lead to improved cardiovascular risk assessments, enabling earlier detection and better management of heart disease.
How similar studies have gone: Other research has shown promise in developing advanced lipoprotein testing methods, indicating that this approach has potential for success.
Where this research is happening
-
Electronic Biosciences, INC.
San Diego, United States Active
Researchers
- Principal investigator: German, Sean — Electronic Biosciences, INC.
- Study coordinator: German, Sean
Related research
Other NIH-funded projects on the same topics.
-
Cardiovascular risk planning and reduction for men with prostate cancer
A program to better predict and reduce heart disease risk in men treated for prostate cancer, especially older patients.
-
Traumatic Stress, Epigenetic Aging, and Heart Risk in Veterans
A large study using Veterans Affairs data to see if traumatic stress and faster biological aging relate to higher risk of stroke and heart disease.
-
Lifestyle plan to protect muscle and heart health for adults with obesity using GLP-1 medications
A real-world trial tests a combined nutrition and resistance-training program versus standard care for adults starting GLP-1 weight loss drugs to preserve lean mass and cardiovascular health.
-
Role of the body's natural cannabis-like system in diabetes progression and heart risk
This grant studies how the body's endocannabinoid system affects the progression from obesity to diabetes and the associated risk for cardiovascular disease in adults.
-
Community and Peer Support for Reducing Cardiovascular Risk
Aims to understand how community and peer programs can help people lower cardiovascular risk, by analyzing existing programs and how their implementation and social support influence outcomes.
-
CardioPredict ML: A smarter way to gauge heart risk before pregnancy
A machine learning tool helps identify women at risk for pregnancy-related heart problems before conception, using health records and prior pregnancy data.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.